View BioMarin Pharmaceutical Inc. BMRN stock quote prices, financial information, real-time forecasts, and company news from CNN.

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 7.3% in the afternoon session after the ...

On Friday, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) agreed to acquire Amicus Therapeutics, Inc. (NASDAQ: FOLD) for a total equity value of about $4.8 billion. "Immediately upon close, this ...

BioMarin Pharmaceutical (BMRN) has been in focus after raising its 2026 revenue guidance to US$3.83b to US$3.93b and sharing new VOXZOGO data that broaden attention on the drug’s health impact beyond ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the stocks that could 10x by 2030. On May 22, H.C. Wainwright reiterated a Neutral rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) with a $50 ...

BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in a late-stage ENPP1 ...

BioMarin Pharmaceuticals Inc. BMRN stock is trading higher on Thursday as the company is celebrating positive results from ...

Investors in BioMarin Pharmaceutical Inc (Symbol: BMRN) saw new options begin trading today, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to ...

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and ...

Investors in BioMarin Pharmaceutical Inc (Symbol: BMRN) saw new options become available today, for the August 2026 expiration. One of the key data points that goes into the price an option buyer is ...